A PYMNTS Company

Medical Device Supplier Resolves CMA Concerns

By  |  November 4, 2020
Medical

Stryker Corporation (Stryker) and Wright Medical Group N.V. (Wright) both manufacture a range of orthopaedic products for patients requiring implants in their feet, ankles and hands. Following an initial Phase 1 investigation in June, the Competition and Markets Authority (CMA) was concerned that the £4.2 billion merger between the 2 companies would have a negative impact on vulnerable patients in the UK who need ankle replacements.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Stryker has now offered to sell off its global total ankle replacement product and assets to Colfax Corporation (Colfax) who will incorporate this into their subsidiary, DJO Global. The CMA is satisfied that this full structural divestment will address its competition concerns.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    The CMA has been co-operating closely with the US Federal Trade Commission (FTC), which has also been reviewing the merger. In August, the CMA announced that it had agreed to extend its consideration of an acceptable divestment package in order to align with the FTC’s timing and ensure that the divestment package would be acceptable in both UK and US jurisdictions.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.